All Updates

All Updates

icon
Filter
M&A
Naplasol acquires Mycorena after bankruptcy filing
Food Waste
Aug 23, 2024
This week:
Management news
6K Additive awarded project to develop C-103 powder for additive manufacturing
Additive Manufacturing
Sep 27, 2024
Partnerships
WAAM3D partners with Innovative Space Carrier, Cranfield University, and Aichi Sangyo for space transport development
Additive Manufacturing
Sep 19, 2024
Funding
INFINIT raises USD 6 million in funding to enhance infrastructure
Decentralized Finance (DeFi)
Yesterday
Product updates
Salesforce announces suite of AI-powered autonomous agent solutions
Workflow Automation Platforms
Yesterday
FDA approval
FDA approves Apple AirPods Pro as over-the-counter hearing aids
Age Tech
Yesterday
Partnerships
Paradigm Health and Sheba Medical partner to optimize clinical trials
Clinical Trial Technology
Yesterday
Funding
XP Health raises USD 33.2 million in Series B funding to expand vision care platform
Health Benefits Platforms
Yesterday
Product updates
Circle expands Web3 Services product suite to Arbitrum
Web3 Ecosystem
Yesterday
Management news
Exiger achieves FedRAMP Moderate Authorization for Federal Cloud
Supply Chain Tech
Yesterday
Product updates
Schouten Europe launches plant-based chicken schnitzel with new fiber technology
Plant-based Meat
Yesterday
Aug 23, 2024

Naplasol acquires Mycorena after bankruptcy filing

M&A

  • Naplasol, a member of the VEOS Group specializing in biomass fermentation for mycoprotein production, has acquired Swedish mycoprotein company Mycorena for an undisclosed sum.

  • Mycorena, founded in 2017,  is known for its flagship product, "Promyc," a mycoprotein with a neutral taste and fibrous texture. Its portfolio also included Mycolein, a fungi-based fat product, and Mycoprotein Extrusion and Alignment Technology (M.E.A.T) for creating whole cuts of meat with fibrous structures. Further, the company has introduced consumer products in six EU countries through partnerships with companies like Peas of Heaven , Rebl Eats , and RIP (Rich in Plants) .

  • Naplasol plans to produce Promyc at its industrial facility in Bree, Belgium, to enhance its portfolio and offer new sustainable proteins. The acquisition is expected to benefit both companies through complementary knowledge and products.

  • Analyst QuickTake: Mycorena filed for bankruptcy earlier this year after facing significant financial challenges. The company's acquisition quickly reaffirms its ability to provide lucrative opportunities in alternative proteins due to its many patents, trademarks, and other valuable assets. Further, it highlights the potential of mycoprotein as a sustainable protein ingredient. 

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.